The law of unintended consequences is inescapable! I have summarized the topic in general and have highlighted the recent NEJM opinion article that reflects the mainstream medical view.
Clinical/Medical
"Pill Penalty" and Portfolio Prioritization*: For Biotech CMOs and CSOs
"Pill Penalty" and Portfolio Prioritization*: For Biotech CMOs and CSOs
*There are loopholes, apparently
Clinical/Medical
We dive into clinical data, scrutinizing trials to guide smarter drug development. From vaccines to therapies, we question assumptions and unpack what the evidence really says. Join us to explore how rigorous analysis shapes treatments, saves lives, and keeps pharma honest.
We dive into clinical data, scrutinizing trials to guide smarter drug development. From vaccines to therapies, we question assumptions and unpack what the evidence really says. Join us to explore how rigorous analysis shapes treatments, saves lives, and keeps pharma honest.